Ginsenoside rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma

HIGHLIGHTS

• who: Hyun Ji Hwang from the DepartmentHanyang University have published the research work: Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma, in the Journal: Scientific Reports Scientific Reports
• what: The authors demonstrated that ginsenoside enhances the sensitivity of sunitinib to inhibit the proliferation of renal cell carcinoma cells via induction of cell cycle arrest.
• how: The authors conducted combination treatment experiments using Rg3 10 u03bcM Rh2 10 u03bcM and sunitinib 10 u03bcM concentrations that reduced cell viability by about 50% in all three . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.